• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Exclusives
    • Nutraceuticals
    • Markets
    • Health
    • Jobs
    • Events
    • Buyers' Guide
    • Showcases
    • More
  • Magazine
  • News
  • Exclusives
  • Nutraceuticals
  • Markets
  • Health
  • Jobs
  • Events
  • Buyers' Guide
  • Showcases
  • Current & Past Issues
    Features
    Columns
    Editorials
    Digital Edition
    Subscribe Now
    Advertise Now
    eNewsletter
    Editorial Guidelines
    Top Features
    Reinforcing Omega-3 Supply Networks

    A Clearer Path to Weight Management: The Ozempic Factor

    Under Pressure: Stress and Mental Health Have Taken Center Stage

    Sustainable Business Development: Principles and Strategies for Progress

    Beauty IO MarketWatch: L’Oréal to Define the Next Era of Beauty Tech in CES 2024 Keynote
    Breaking News
    Certifications, Approvals and Patents
    Exclusives
    Industry & Market News
    People
    Products
    Regulatory
    Glossary
    Research
    Supplier News
    Supplier Insights
    Live From Shows
    Top News
    D2C Supplement Brand Launches Blood Sugar Support Supplement, Gluco-Control

    Natrol Launches First Non-Melatonin Sleep Supplement

    Metagenics Releases Consumer Survey on Menopausal Support Supplement

    Culturelle Probiotics Launches Women’s Health Awareness Campaign

    Women's Health Brand O Positiv Launches Essentials Line of Supplements
    Exclusives
    Blogs & Guest Articles
    Health E-Insights
    Area Code 420
    eBook
    Antioxidants
    Dairy-Based Ingredients
    Enzymes
    Fatty Acids
    Fiber & Carbohydrates
    Green Foods
    Herbs & Botanicals
    Marine Nutraceuticals
    Minerals
    Omega 3s
    Probiotics & Prebiotics
    Proteins, Peptides, Amino Acids
    Sweeteners
    Vitamins

    D2C Supplement Brand Launches Blood Sugar Support Supplement, Gluco-Control

    Natrol Launches First Non-Melatonin Sleep Supplement

    Metagenics Releases Consumer Survey on Menopausal Support Supplement

    Women's Health Brand O Positiv Launches Essentials Line of Supplements

    Growing Mushrooms At Home With Mistercap, Wiz Khalifa
    Consumer Trends
    Contract Manufacturing
    Cosmeceuticals / Nutricosmetics
    Delivery & Dosage Technologies
    Dietary Supplements
    Flavors & Colors
    Functional Foods & Beverages
    Healthcare Trends
    Medical Nutrition
    Mergers & Acquisitions
    Natural/Organic
    Nutrition Bars
    Packaging
    Pet Nutraceuticals
    Quality & Safety
    Regulations
    Research
    Testing
    World Markets

    D2C Supplement Brand Launches Blood Sugar Support Supplement, Gluco-Control

    Natrol Launches First Non-Melatonin Sleep Supplement

    Metagenics Releases Consumer Survey on Menopausal Support Supplement

    Culturelle Probiotics Launches Women’s Health Awareness Campaign

    Women's Health Brand O Positiv Launches Essentials Line of Supplements
    Bone & Joint Health
    Cancer Risk
    Cardiovascular Health
    Cognitive Function
    Diabetes & Blood Sugar Management
    Digestive Health
    Energy
    Eye Health
    Healthy Aging
    Immune Function
    Infant & Children's Health
    Inflammation
    Men's Health
    Mood Health & Sleep
    Oral Health
    Sexual & Reproductive Health
    Skin Health
    Sports Nutrition
    Weight Management/Weight Loss
    Women's Health

    D2C Supplement Brand Launches Blood Sugar Support Supplement, Gluco-Control

    Natrol Launches First Non-Melatonin Sleep Supplement

    Metagenics Releases Consumer Survey on Menopausal Support Supplement

    Culturelle Probiotics Launches Women’s Health Awareness Campaign

    Women's Health Brand O Positiv Launches Essentials Line of Supplements
    Industry Events
    Live From Show Events
    Webinars
    All Companies
    Categories
    Trade Associations
    Company Capabilities
    International Buyers Guide Companies
    CoQ10 Association

    Trust Transparency Consulting

    JRS Pharma

    Applied Food Sciences, Inc.

    Bioenergy Life Science, Inc. (BLS)
    Companies
    Product Releases
    News Releases
    Literature / Brochures
    White Papers
    Jobs
    VIdeos
    Services
    Add New Company
    International Buyers Guide Companies
    CoQ10 Association

    Trust Transparency Consulting

    JRS Pharma

    Applied Food Sciences, Inc.

    Bioenergy Life Science, Inc. (BLS)
    • Magazine
      • Current / Back Issue
      • Features
      • Editorial
      • Columns
      • Digital Edition
      • eNewsletter Archive
      • Editorial Guidelines
      • Subscribe Now
      • Advertise Now
    • Breaking News
    • Buyers' Guide
      • All Companies
      • Categories
      • Trade Associations
      • Company Capabilities
    • Nutraceuticals
      • Antioxidants
      • Dairy-Based Ingredients
      • Enzymes
      • Fatty Acids
      • Fiber & Carbohydrates
      • Green Foods
      • Herbs & Botanicals
      • Marine Nutraceuticals
      • Minerals
      • Omega 3s
      • Probiotics & Prebiotics
      • Proteins, Peptides, Amino Acids
      • Sweeteners
      • Vitamins
    • Markets
      • Consumer Trends
      • Contract Manufacturing
      • Cosmeceuticals / Nutricosmetics
      • Delivery & Dosage Technologies
      • Dietary Supplements
      • Flavors & Colors
      • Functional Foods & Beverages
      • Healthcare Trends
      • Medical Nutrition
      • Mergers & Acquisitions
      • Natural/Organic
      • Nutrition Bars
      • Packaging
      • Pet Nutraceuticals
      • Quality & Safety
      • Regulations
      • Research
      • Testing
      • World Markets
    • Health
      • Bone & Joint Health
      • Cancer Risk
      • Cardiovascular Health
      • Cognitive Function
      • Diabetes & Blood Sugar Management
      • Digestive Health
      • Energy
      • Eye Health
      • Healthy Aging
      • Immune Function
      • Infant & Children's Health
      • Inflammation
      • Men's Health
      • Mood Health & Sleep
      • Oral Health
      • Sexual & Reproductive Health
      • Skin Health
      • Sports Nutrition
      • Weight Management/Weight Loss
      • Women's Health
    • Online Exclusives
    • Webinars
    • Slideshows
    • Blogs & Guest Articles
    • Health E-Insights
    • Videos
    • Podcasts
    • Infographics
    • eBook
    • Whitepapers
    • Research
      • TrendSense
      • Monograph Center
      • White Papers
      • Research News
    • Jobs
    • Events
      • Industry Events
      • Live From Show Events
      • Webinars
    • Supplier Showcases
      • Companies
      • Product Releases
      • News Releases
      • Literature / Brochures
      • White Papers
      • Jobs
      • VIdeos
      • Services
    • About Us
      • About Us
      • Contact Us
      • Advertise With Us
      • Privacy Policy
      • Terms of Use
    Columns

    FDCA Preemption of State-Level Misbranding Laws for Structure/Function Ingredient Claims

    If a claim describes the substantiated role a nutrient or dietary ingredient plays in the body, plaintiffs cannot survive a motion for summary judgment.

    FDCA Preemption of State-Level Misbranding Laws for Structure/Function Ingredient Claims
    By Todd Harrison, Partner; Richard Starr, Associate; and Olisa Onyiuke, Associate, Venable06.02.22
    If you are a marketer or manufacturer of dietary supplements, the specter of being sued in a class action over label and advertising claims is always present. This is especially true when making structure/function claims.

    Recent court cases, however, cast doubt on whether a plaintiff can successfully sue a company over basic structure/function claims. A case out of the U.S. District Court of Massachusetts highlights this issue, but cases out of the 9th Circuit of Appeals also add more credence to the trend.

    In Ferrari v. Vitamin Shoppe, Inc., No. CV 17-10475-GAO, 2022 WL 974048 (D. Mass. Mar. 31, 2022), a federal judge found that proposed class action allegations that Vitamin Shoppe, Inc. violated state statutes for false advertising and deceptive business practices were preempted by the Federal Food, Drug, and Cosmetic Act (FDCA) as amended by the Dietary Supplement Health and Education Act. While the opinion appears to present a unique perspective on the FDCA’s preemptive power for dietary supplement structure/function claims, the case can also be read to be consistent with “lack of substantiation” cases.

    The added twist in Ferrari is the court found the plaintiff’s claims preempted because Vitamin Shoppe’s claims met the requirements of §403(r)(6) of the FDCA, which specifically allows dietary supplement companies to make structure/function claims if they have substantiation to support the claim.

    The Ferrari v. Vitamin Shoppe View of FDCA Preemption

    On Mar. 31, the U.S. District Court for the District of Massachusetts ruled on a class action lawsuit against Vitamin Shoppe involving structure/function ingredient claims for dietary supplements.

    The plaintiffs, Richard Ferrari and William Bohr, alleged that Vitamin Shoppe’s product labeling contained statements that induced them to buy the products, only to find out that the products did not yield the results they were promised. Vitamin Shoppe promoted its products by highlighting glutamine, the products’ major ingredient, as one that “has been shown to possess anti-catabolic properties to help preserve muscle,” “helps support muscle growth and recovery as well as immune health,” and “is involved in regulating protein synthesis.”

    The plaintiffs alleged that they did not experience improved muscle growth after consuming the product, and that Vitamin Shoppe’s claims are unsubstantiated because the company disregarded several studies stating that glutamine had not been shown to promote muscle growth when abiding by the product’s intended use.

    The District Court granted summary judgment in favor of Vitamin Shoppe on the premise that the plaintiff’s state law claims were preempted by the FDCA. The court specifically found that the FDCA creates statutory requirements for a structure/function claim and if those requirements are met, then the plaintiff’s false advertising cause of action is precluded.

    In this regard, a structure/function claim must describe the general effects of a nutrient or dietary ingredient by which it may affect the structure/function of the body (and the claim does not apply to the finished product). This latter issue is of importance and is consistent with the trend to require a structure/function claim be tied to the ingredient as opposed to the whole product. (The logic of this position has always been nonsensical and should apply to the finished product, not just an ingredient claim. With that said, it has long been the position of FDA, the FTC, and NAD that the claim should be tied to the ingredient as opposed to the product.)

    A company must have substantiating evidence and the product must include a disclaimer that the claim has not been evaluated by FDA. Lastly, the claim cannot expressly or implicitly imply that the ingredient diagnoses, treats, cures, or prevents a specific disease (i.e., not disease claim). (See 21 U.S.C.A. § 403(r)(6); 21 CFR 101.93(f).)

    The court further reasoned that the FDCA prohibits states from creating any labeling requirement for dietary supplements that is “not identical to” the requirements articulated in § 403(r)(6). This means that any cause of action arising under a state law cannot create a different labeling standard than those of § 403(r)(6), and is preempted by the FDCA. 

    Properly Stated and Requisite Substantiation

    In Ferrari, the court ruled that the plaintiff’s state law misbranding allegation was preempted by the FDCA, as Vitamin Shoppe had the requisite substantiation to support glutamine’s anti-catabolic properties. The court further noted that all the other requisite requirements of the FDCA were met. The court found the plaintiff’s contrary evidence was irrelevant when the plaintiff’s expert agreed that the structure/function claim was consistent with the known role that glutamine plays in the body. In fact, the plaintiff’s expert agreed on glutamine’s basic properties, including that it generally supports muscle growth.

    The court emphasized that a properly stated structure/function claim is neither inherently false nor misleading because the substantiation requirement is baked into the § 403(r)(6) requirements. The court then indicated that agreeing with the plaintiff’s argument would add additional requirements that are not included in § 403(r)(6). To state it differently, the court found that it was unnecessary for Vitamin Shoppe to overcome negative evidence as the claims properly described the role glutamine plays in the body. 

    The emphasis on glutamine as an ingredient as opposed to the product in general cannot be ignored. More specifically, the court is strongly suggesting if the claim relates to the established role a nutrient or dietary ingredient plays in the body then it, in essence, creates a safe harbor for companies even if there is evidence the dose level is not sufficient to support the claim. 

    Indeed, this makes sense as nutrients and dietary ingredients are supportive in nature. Absent a performance claim (e.g., “gain 10 pounds of muscle in 30-days”), the defendant properly described the role of glutamine. And there would be no desire on anyone’s part to conduct a clinical study to see if something is simply supportive when its role is already established and known.

    Consistent with Ninth Circuit Confirmation

    Importantly, the court’s reasoning in Ferrari is also consistent with the 9th Circuit Court of Appeals, the Circuit Court most willing, in earlier cases, to permit false advertising lawsuits. The decision in Vitamin Shoppe continues the trend of FDCA preemption of state advertising structure/function ingredient claims.

    The Ninth Circuit Court of Appeals has been grappling with this particular issue. In Dachauer v. NBTY, Inc., the Ninth Circuit held that FDCA, as amended by the Nutrition Labeling and Education Act, contains an express preemption provision that directly applied to structure/function claims (913 F.3d 844 (9th Cir. 2019)).

    The plaintiff in Dachauer claimed that the defendant’s vitamin E supplements were misleading because the supplements did not prevent cardiovascular disease even though the labeling stated it promotes and supports cardiovascular, circulatory, and heart health.

    Like the plaintiff’s argument in Ferrari, the plaintiff’s expert in Dachauer offered evidence that vitamin E supplements taken at the recommended dosage did not prevent cardiovascular disease. The court found that the FDCA preempted the state law claim so long as the structure/function claim was substantiated and met all of FDCA’s narrow requirements.

    The court stated unequivocally that “manufacturers need not also have evidence that [vitamin E] structural or functional effects reduce the risk of developing a certain disease.” The court emphasized that this distinction is the whole point of the § 403(r)(6) structure/function claim carveout: to distinguish between the role a nutrient or dietary ingredient plays in supporting the structure/function of the body without requiring FDA-approval.

    For example, in this case, preventing cardiovascular disease is an impermissible disease claim while supporting cardiovascular health is a permissible structure/function claim for a dietary supplement.

    Similarly, the Ninth Circuit addressed another structure/function preemption case in Kroessler v. CVS Health Corp. The court held that the plaintiff’s claims were not preempted by FDCA’s standard (977 F.3d 803 (9th Cir. 2020)). The plaintiff alleged the defendant’s statements “supports flexibility” and “helps support and maintain the structure of joints” on its glucosamine supplements were false and misleading because it is known that glucosamine does not have those effects, and the defendant lacked substantiation for these structure/function claims.

    The major difference here is that the defendant’s marketing stated that its glucosamine-based supplements as a finished product maintain or support joint health. The Ninth Circuit held that there was no preemption because a plaintiff can bring claims if alleging that the requirements of a structure/function claim have not been met, such as improper substantiation.

    The court elaborated that the FDCA does not preempt state law (in this instance, California state law) because the challenged statement is a proper structure/function claim; but rather, preemption exists only if a “plaintiff’s legal claims and factual allegations would hold a defendant to a different substantiation standard than the FDCA.” 

    With that said, the 9th Circuit decision in Greenberg v. Target Corp. (985 F.3d 650 (9th Cir. 2021)) makes it clear there is no requirement that consumers derive health benefits from the supplement in line with the structure/function claims. Rather, the 9th Circuit held “[t]o substantiate [a structure/function] claim, supplement manufacturers need only show evidence that an ingredient has an effect on small aspect of the [specified bodily] structure/function.” (See Greenberg, 985 F.3d at 653.)

    Similar to Ferrari , experts for both sides in Greenberg agreed that the nutrient biotin is known for its “cellular and biochemical role in the support of healthy hair and skin.” Furthermore, the defendant fulfilled all the FDCA structure/function requirements for its biotin supplements. Thus, the 9th Circuit ruled against the plaintiff and for the defendant because the claims were preempted.

    Key Takeaways

    The Ferrari decision and the decisions out of the 9th Circuit clearly show that false advertising class actions are not going away. However, these decisions as well as others regarding “lack of substantiation” clearly demonstrate the courts may finally be growing wary of these lawsuits when the defendant has complied with the requirements of § 403(r)(6) of the FDCA.

    More specifically, if the claim specifically describes the accepted role a nutrient or dietary ingredient plays in supporting the structure/function of the body, the claim should be dismissed since the claim is clearly permitted under the law and it accurately describes the known role the nutrient or dietary ingredient plays in the body. Stated differently, the emerging case law indicates that if the claim describes the known role a nutrient or dietary ingredient plays in the body and there is substantiation to support this role, the plaintiff cannot survive a motion for
    summary judgment. 

    From a practical perspective, a company should consider tying the structure/function claim to specific nutrients whose mechanism of action or role it plays in the body is established. This places the company in the best possible position to defend against potential class action lawsuits for false advertising. That said, dietary supplement companies should remain vigilant about structure/function regulatory compliance to ensure they remain under the preemptive protection of the FDCA.


    About the Author: Todd Harrison is partner with Venable, which is located in Washington, D.C. He advises food and drug companies on a variety of FDA and FTC matters, with an emphasis on dietary supplement, functional food, biotech, legislative, adulteration, labeling and advertising issues. He can be reached at 575 7th St. NW, Washington, D.C. 20004, Tel: 202-344-4724; E-mail: taharrison@venable.com.
    Related Searches
    • Regulations
    • Dietary Supplements
    Related Knowledge Center
    • Dietary Supplements
    • Regulations
    Suggested For You
    SGS SGS
    Supplyside West Event Info Supplyside West Event Info
    Dyna-Tabs, LLC Dyna-Tabs, LLC
    Medical Sales Representative – Riverside, CA Medical Sales Representative – Riverside, CA
    Medical Sales Representative – Columbus, OH Medical Sales Representative – Columbus, OH
    What’s Up With Supps to Host SupplySide West Closing Party What’s Up With Supps to Host SupplySide West Closing Party
    Ashwagandha Extract Linked to Mood and Cognitive Benefits in Several New Studies Ashwagandha Extract Linked to Mood and Cognitive Benefits in Several New Studies
    Natural Products Technical Support Specialist - Barrington, IL Natural Products Technical Support Specialist - Barrington, IL
    Eurofins Adopts California Poppy Through ABC’s Adopt-an-Herb Program Eurofins Adopts California Poppy Through ABC’s Adopt-an-Herb Program
    Sustainable Business Development: Principles and Strategies for Progress  Sustainable Business Development: Principles and Strategies for Progress
    Mind The Gaps: Supporting Voices of BIPOC-Owned Wellness Businesses Mind The Gaps: Supporting Voices of BIPOC-Owned Wellness Businesses
    Introducing the Happi & Nutraceuticals World Wellness Conference & Tabletop Exhibition Introducing the Happi & Nutraceuticals World Wellness Conference & Tabletop Exhibition
    Nicole Johnson-Hoffman Joins Meati Board of Directors Nicole Johnson-Hoffman Joins Meati Board of Directors
    Fenugreek Extract Linked to Exercise, Body Composition Benefits in Healthy Women Fenugreek Extract Linked to Exercise, Body Composition Benefits in Healthy Women
    Botanic Healthcare, launched the website of its branded ingredients: Lutenic™ and AbsoCurcumin® Botanic Healthcare, launched the website of its branded ingredients: Lutenic™ and AbsoCurcumin®

    Related Buyers Guide Companies

    • SGS

      SGS

      ...
      Michelle Lee, Marketing Analyst 09.28.23

    • Supplyside West Event Info

      Supplyside West Event Info

      ...
      09.27.23

    • Dyna-Tabs, LLC

      ...
      HAROLD BAUM, MANAGING DIRECTOR 09.26.23


    • Medical Sales Representative – Riverside, CA

      Medical Sales Representative – Riverside, CA

      We are seeking a highly motivated and pro-active Medical Sales Representative to join our team.

    • Medical Sales Representative – Columbus, OH

      Medical Sales Representative – Columbus, OH

      We are seeking a highly motivated and pro-active Medical Sales Representative to join our team.

    Loading, Please Wait..
    Trending
    • Soviets Took Probiotics To The Next Level
    • Todd Spear Joins Protein Research As VP Of Sales And Marketing
    • Growing Mushrooms At Home With Mistercap, Wiz Khalifa
    • New Technology Converts Sugar In Juice To Fiber
    Breaking News
    • D2C Supplement Brand Launches Blood Sugar Support Supplement, Gluco-Control
    • Natrol Launches First Non-Melatonin Sleep Supplement
    • Metagenics Releases Consumer Survey on Menopausal Support Supplement
    • Culturelle Probiotics Launches Women’s Health Awareness Campaign
    • Women's Health Brand O Positiv Launches Essentials Line of Supplements
    View Breaking News >
    CURRENT ISSUE

    September 2023

    • A Clearer Path to Weight Management: The Ozempic Factor
    • Under Pressure: Stress and Mental Health Have Taken Center Stage
    • Sustainable Business Development: Principles and Strategies for Progress
    • BIOHM Health Targets ‘Digestive Plaque’ with Probiotic, Fungus, and Enzyme Formula
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    D2C Supplement Brand Launches Blood Sugar Support Supplement, Gluco-Control
    Natrol Launches First Non-Melatonin Sleep Supplement
    Metagenics Releases Consumer Survey on Menopausal Support Supplement
    Coatings World

    Latest Breaking News From Coatings World

    Coating Additives Market Worth $10.5B by 2028: MarketsandMarkets
    California Sports Surfaces Celebrates 70 Years
    ROSS Offers Cost-Effective, Expertly Reconditioned Equipment
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    MPO's Most-Read Stories This Week—Sept. 30
    Dentsply Sirona Names Former NuVasive CEO Lucier as Chairman
    SeaStar Medical Gets Breakthrough Nod for Selective Cytopheretic Device
    Contract Pharma

    Latest Breaking News From Contract Pharma

    Univercells Expands into the U.S. With New Offices in Andover, MA
    Evecxia Therapeutics, Quotient Sciences Complete Clinical Milestone for Depression Treatment
    Ionis, Roche Partner on RNA-targeted Programs for AD and HD
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    ScentAir Debuts Room Sprays & More
    African Pride Launches On-Campus Activations
    Sharper Image Debuts Revel Hair Tools
    Happi

    Latest Breaking News From Happi

    Is Dr. Barbara Sturm Skincare Considering a Sale?
    YSL Beauty Welcomes Five Foremost Artists to Represent New Fragrance
    Christian Siriano Appointed Olay’s First Chief Drop Officer
    Ink World

    Latest Breaking News From Ink World

    MicroDynamics, All Printing Resources Partner to Represent Veritas
    Weekly Recap: Wikoff Color, BASF, Latin America Top This Week’s Stories
    Siegwerk’s Climate Targets Validated by SBTi
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    TLMI's LLT grows, Labelexpo Europe details big numbers and more
    SABIC and partners launch bio-based IML solution for food packaging
    tesa completes expansion of Michigan manufacturing facility
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    Greentech Introduces Air Filter with Advanced Odor Elimination
    Ontex Divests Pakistan Operations to ASAIA Holding
    Goodnites Bedwetting Underwear Recognized by Good Housekeeping
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    ODT's Most-Read Stories This Week—Sept. 30
    Lazurite Adds Benchmark Medical as a Distributor for its ArthroFree Wireless Camera System
    ChitogenX Granted New U.S., Canadian ORTHO-R Patent
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    Weekly Recap: Mergers and Acquisitions, First Solar Top This Week’s Stories
    Jabil Posts Fourth Quarter, Fiscal Year 2023 Results
    Ink-Borne ‘Chiplets’ Could Lead to Printable Displays, Electronics and More

    Copyright © 2023 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login